Ad
TIL Stock Quote Trading Chart Instil Bio Inc.
Quote | Instil Bio Inc. (NASDAQ:TIL)
| Last: | $0.416 |
|---|---|
| Change Percent: | -1.32% |
| Open: | $0.4284 |
| Close: | $0.416 |
| High: | $0.439 |
| Low: | $0.4101 |
| Volume: | 78,226 |
| Last Trade Date Time: | 09/22/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
TIL Last Five Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $0.416 | $0.4284 | $0.416 | $0.439 | $0.4101 | 78,226 | 09-22-2023 |
| $0.4228 | $0.42 | $0.4228 | $0.43 | $0.4095 | 161,948 | 09-21-2023 |
| $0.425 | $0.446 | $0.425 | $0.446 | $0.421 | 109,162 | 09-20-2023 |
| $0.44 | $0.435 | $0.44 | $0.44685 | $0.415 | 333,397 | 09-19-2023 |
| $0.429 | $0.448 | $0.429 | $0.4546 | $0.425 | 131,603 | 09-18-2023 |
| $0.4273 | $0.456 | $0.4273 | $0.48 | $0.4273 | 1,059,977 | 09-15-2023 |
| $0.4701 | $0.4663 | $0.4701 | $0.487351 | $0.4663 | 407,350 | 09-14-2023 |
| $0.479 | $0.480101 | $0.479 | $0.489899 | $0.47 | 404,236 | 09-13-2023 |
| $0.48 | $0.4667 | $0.48 | $0.4913 | $0.4667 | 577,392 | 09-12-2023 |
| $0.4616 | $0.465 | $0.4616 | $0.478826 | $0.46 | 220,027 | 09-11-2023 |
| $0.4631 | $0.44 | $0.4631 | $0.4757 | $0.43 | 544,652 | 09-08-2023 |
| $0.44 | $0.431 | $0.44 | $0.4514 | $0.431 | 747,436 | 09-07-2023 |
| $0.431 | $0.44 | $0.431 | $0.45 | $0.426 | 252,820 | 09-06-2023 |
| $0.4451 | $0.47 | $0.4451 | $0.484 | $0.41 | 738,256 | 09-05-2023 |
| $0.456 | $0.44 | $0.456 | $0.4828 | $0.44 | 151,541 | 09-04-2023 |
| $0.456 | $0.44 | $0.456 | $0.4828 | $0.44 | 151,541 | 09-01-2023 |
| $0.4511 | $0.447 | $0.4511 | $0.4671 | $0.447 | 298,889 | 08-31-2023 |
| $0.4465 | $0.45 | $0.4465 | $0.4676 | $0.441 | 223,852 | 08-30-2023 |
| $0.45 | $0.45 | $0.45 | $0.474 | $0.44 | 205,852 | 08-29-2023 |
| $0.45 | $0.467 | $0.45 | $0.468 | $0.45 | 133,732 | 08-28-2023 |
Instil Bio Inc. Company Name:
TIL Stock Symbol:
NASDAQ Market:
Ad
-
Better For You Wellness, Inc. (OTCQB: BFYW), an Ohio-based wellness company at the forefront of plant-based and scien...
-
ITIL-306, first CoStAR-TIL in clinical development, anticipated to start clinical trial ITIL-306-202 in 2H 2023 Initial data from ITIL-306-202 clinical trial anticipated in 2024 ITIL-306 operational in Manchester, UK manufacturing facility with additional process improvements ...
-
Presented data showing that folate receptor α (FRα)-CoStAR enhanced activity of TILs against autologous NSCLC, ovarian, and renal tumors ITIL-306, first CoStAR-TIL in clinical development, anticipated to resume clinical study in 2H 2023 Initial clinical data from ITI...